Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Ehrlich

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Cancer|February 24, 2024
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2Daniel J Benedetti, Lindsay A Renfro, Ian Tfirn, et al.
Journal of Pediatric Surgery|January 22, 2013
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committeeKenneth W Gow, Douglas C Barnhart, Thomas E Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 StudyDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 25, 2022
ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Cancer|February 24, 2024
Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2Daniel J Benedetti, Lindsay A Renfro, Ian Tfirn, et al.
Journal of Pediatric Surgery|January 22, 2013
Primary nephrectomy and intraoperative tumor spill: report from the Children's Oncology Group (COG) renal tumors committeeKenneth W Gow, Douglas C Barnhart, Thomas E Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2018
Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 StudyDavid B Dix, Nita L Seibel, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 25, 2022
ASO Video Abstract: Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis-A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Nature Reviews. Urology|June 20, 2025
Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trialsDaniel J Benedetti, Nicholas G Cost, Peter F Ehrlich, et al.
Pediatric Blood & Cancer|May 14, 2025
Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology PerspectivesKathryn S Sutton, Amy L Walz, Alissa Groenendijk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2019
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study ReportDavid B Dix, Conrad V Fernandez, Yueh-Yun Chi, et al.
Annals of Surgical Oncology|January 24, 2022
Kidney Preservation and Wilms Tumor Development in Children with Diffuse Hyperplastic Perilobar Nephroblastomatosis: A Report from the Children's Oncology Group Study AREN0534Peter F Ehrlich, Brett Tornwall, Murali M Chintagumpala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
Impact of Pulmonary Tumor Burden in Favorable Histology Wilms Tumor Outcomes: A Report From the Children's Oncology Group Study AREN0533David B Dix, Geetika Khanna, Lindsay A Renfro, et al.
Pageof 19